{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:25Z","timestamp":1792787785008,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key project of Aerospace Medical Health Technology Group Co., LTD","award":["2023YK18"],"award-info":[{"award-number":["2023YK18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04609-8","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T02:42:09Z","timestamp":1742006529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The comparative study of the efficacy of recombinant human brain natriuretic peptide combined with vasoactive medications for elderly patients with heart failure and hypotension receiving injections"],"prefix":"10.1186","volume":"25","author":[{"given":"Rui","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helu","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"issue":"10","key":"4609_CR1","doi-asserted-by":"publisher","first-page":"e010080","DOI":"10.1161\/CIRCHEARTFAILURE.122.010080","volume":"15","author":"A Peikert","year":"2022","unstructured":"Peikert A, Martinez FA, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS, de Boer RA, DeMets D, Hernandez AF, et al. Efficacy and safety of Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to age: the DELIVER trial. Circulation Heart Fail. 2022;15(10):e010080.","journal-title":"Circulation Heart Fail"},{"issue":"5","key":"4609_CR2","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.numecd.2023.01.004","volume":"33","author":"L Liang","year":"2023","unstructured":"Liang L, Zhao X, Huang L, Tian P, Huang B, Feng J, Zhou P, Wang J, Zhang J, Zhang Y. Prevalence and prognostic importance of malnutrition, as assessed by four different scoring systems, in elder patients with heart failure. Nutr Metabolism Cardiovasc Diseases: NMCD. 2023;33(5):978\u201386.","journal-title":"Nutr Metabolism Cardiovasc Diseases: NMCD"},{"issue":"5","key":"4609_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.hrtlng.2020.03.023","volume":"49","author":"G G\u00f6k","year":"2020","unstructured":"G\u00f6k G, K\u0131l\u0131\u00e7 S, Sinan \u00dcY, Turkoglu E, Kemal H, Zoghi M. Epidemiology and clinical characteristics of hospitalized elderly patients for heart failure with reduced, mid-range and preserved ejection fraction. Heart Lung: J Crit Care. 2020;49(5):495\u2013500.","journal-title":"Heart Lung: J Crit Care"},{"issue":"1","key":"4609_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","volume":"6","author":"M Arrigo","year":"2020","unstructured":"Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, Mebazaa A. Acute heart failure. Nat Reviews Disease Primers. 2020;6(1):16.","journal-title":"Nat Reviews Disease Primers"},{"issue":"6","key":"4609_CR5","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.2337\/dc19-2187","volume":"43","author":"JSS Singh","year":"2020","unstructured":"Singh JSS, Mordi IR, Vickneson K, Fathi A, Donnan PT, Mohan M, Choy AMJ, Gandy S, George J, Khan F, et al. Dapagliflozin versus placebo on left ventricular remodeling in patients with diabetes and heart failure: the REFORM trial. Diabetes Care. 2020;43(6):1356\u20139.","journal-title":"Diabetes Care"},{"issue":"4","key":"4609_CR6","first-page":"2410","volume":"13","author":"J Fang","year":"2021","unstructured":"Fang J, Zeng W. A meta-analysis of the clinical efficacy of RhBNP in treating patients with acute myocardial infarction and heart failure. Am J Translational Res. 2021;13(4):2410\u201321.","journal-title":"Am J Translational Res"},{"issue":"45","key":"4609_CR7","doi-asserted-by":"publisher","first-page":"e35900","DOI":"10.1097\/MD.0000000000035900","volume":"102","author":"J Yang","year":"2023","unstructured":"Yang J, Zhang L, Guo M, Hao M. Effects of Recombinant human brain natriuretic peptide combined with Tolvaptan on cardiac and renal function and serum inflammatory factors in patients with severe heart failure. Medicine. 2023;102(45):e35900.","journal-title":"Medicine"},{"issue":"9","key":"4609_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.14715\/cmb\/2023.69.9.23","volume":"69","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xie C, Hou Y, Li K, Wang Q, Lin L, Tang M, Yang P, Wu J. The effects of prophylactic intravenous injection of RhBNP on prognosis in patients with STEMI undergoing PPCI. Cell Mol Biol. 2023;69(9):156\u201360.","journal-title":"Cell Mol Biol"},{"issue":"8","key":"4609_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.cardfail.2023.04.015","volume":"29","author":"GM Felker","year":"2023","unstructured":"Felker GM, North R, Mulder H, Jones WS, Anstrom KJ, Patel MJ, Butler J, Ezekowitz JA, Lam CSP, O\u2019Connor CM, et al. Classification of heart failure events by severity: insights from the VICTORIA trial. J Card Fail. 2023;29(8):1113\u201320.","journal-title":"J Card Fail"},{"issue":"8","key":"4609_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.5152\/akd.2015.6156","volume":"15","author":"Y \u00c7avu\u015fo\u011flu","year":"2015","unstructured":"\u00c7avu\u015fo\u011flu Y, Korkmaz \u015e, Demirta\u015f S, Gencer E, \u015ea\u015fmaz H, Mutlu F, G\u00fcne\u015f H, Mert UK, \u00d6zdemir S, Kalayc\u0131 S, et al. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with Dobutamine or Levosimendan: IMA-HF study. Anatol J Cardiol. 2015;15(8):611\u20137.","journal-title":"Anatol J Cardiol"},{"issue":"7","key":"4609_CR11","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.cardfail.2022.04.011","volume":"28","author":"T Thorvaldsen","year":"2022","unstructured":"Thorvaldsen T, Ferrannini G, Mellbin L, Benson L, Cosentino F, McMurray JJV, Dahlstr\u00f6m U, Lund LH, Savarese G. Eligibility for Dapagliflozin and empagliflozin in a Real-world heart failure population. J Card Fail. 2022;28(7):1050\u201362.","journal-title":"J Card Fail"},{"issue":"10244","key":"4609_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","volume":"396","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Pedro Ferreira J, Zannad F, Packer M, Fonarow GC, McMurray JJV, Solomon SD. Estimating lifetime benefits of comprehensive disease-modifying Pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Lancet (London England). 2020;396(10244):121\u20138.","journal-title":"Lancet (London England)"},{"issue":"7","key":"4609_CR13","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/os.13303","volume":"14","author":"SK Im","year":"2022","unstructured":"Im SK, Lee JH, Lee KY, Yoo SJ. Effectiveness and feasibility of injectable Escherichia coli-Derived Recombinant human bone morphogenetic Protein-2 for anterior lumbar interbody fusion at the lumbosacral junction in adult spinal deformity surgery: A clinical pilot study. Orthop Surg. 2022;14(7):1350\u20138.","journal-title":"Orthop Surg"},{"issue":"3","key":"4609_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ejhpharm-2021-002748","volume":"30","author":"S Gilliot","year":"2023","unstructured":"Gilliot S, Henry H, Carta N, Genay S, Barth\u00e9l\u00e9my C, D\u00e9caudin B, Odou P. Long-term stability of 10\u00a0mg\/ml Dobutamine injectable solutions in 5% dextrose and normal saline solution stored in polypropylene syringes and cyclic-oleofin-copolymer vials. Eur J Hosp Pharmacy: Sci Pract. 2023;30(3):153\u20139.","journal-title":"Eur J Hosp Pharmacy: Sci Pract"},{"issue":"6","key":"4609_CR15","first-page":"537","volume":"33","author":"LA Gardella","year":"1976","unstructured":"Gardella LA, Kesler H, Carter JE, Zaroslinski JF. Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 2: stability with some commonly used antibiotics in 5% dextrose injection. Am J Hosp Pharm. 1976;33(6):537\u201340.","journal-title":"Am J Hosp Pharm"},{"key":"4609_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijcard.2022.08.009","volume":"369","author":"L Garatti","year":"2022","unstructured":"Garatti L, Frea S, Bocchino PP, Angelini F, Cingolani M, Sacco A, Rondinara GM, Bagnardi V, Sala IM, Kapur NK, et al. Sodium Nitroprusside in acute heart failure: A multicenter historic cohort study. Int J Cardiol. 2022;369:37\u201344.","journal-title":"Int J Cardiol"},{"issue":"1","key":"4609_CR17","doi-asserted-by":"publisher","first-page":"20752","DOI":"10.1038\/s41598-023-48125-1","volume":"13","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Wang X, Yuan H, Wu L, Zhang B, Chen X, Zhang Y. Impact of Recombinant human brain natriuretic peptide on emergency dialysis and prognosis in end-stage renal disease patients with type 4 cardiorenal syndrome. Sci Rep. 2023;13(1):20752.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"4609_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00063-020-00659-2","volume":"115","author":"S John","year":"2020","unstructured":"John S. Lessons learned from kidney dysfunction: preventing organ failure. Medizinische Klinik Intensivmedizin Und Notfallmedizin. 2020;115(Suppl 1):21\u20137.","journal-title":"Medizinische Klinik Intensivmedizin Und Notfallmedizin"},{"issue":"4","key":"4609_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/ehjci\/jex133","volume":"19","author":"TM Gorter","year":"2018","unstructured":"Gorter TM, van Veldhuisen DJ, Voors AA, Hummel YM, Lam CSP, Berger RMF, van Melle JP, Hoendermis ES. Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension. Eur Heart J Cardiovasc Imaging. 2018;19(4):425\u201332.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"15","key":"4609_CR20","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jcin.2019.02.042","volume":"12","author":"KP Rommel","year":"2019","unstructured":"Rommel KP, Besler C, Noack T, Blazek S, von Roeder M, Fengler K, Ender J, Gutberlet M, Desch S, Borger MA, et al. Physiological and clinical consequences of right ventricular volume overload reduction after transcatheter treatment for tricuspid regurgitation. JACC Cardiovasc Interv. 2019;12(15):1423\u201334.","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"4609_CR21","doi-asserted-by":"publisher","first-page":"e0265059","DOI":"10.1371\/journal.pone.0265059","volume":"17","author":"M Vicenzi","year":"2022","unstructured":"Vicenzi M, Caravita S, Rota I, Casella R, Deboeck G, Beretta L, Lombi A, Vachiery JL. The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension. PLoS ONE. 2022;17(5):e0265059.","journal-title":"PLoS ONE"},{"issue":"2","key":"4609_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/1568026611313020002","volume":"13","author":"V Panagopoulou","year":"2013","unstructured":"Panagopoulou V, Deftereos S, Kossyvakis C, Raisakis K, Giannopoulos G, Bouras G, Pyrgakis V, Cleman MW. NTproBNP: an important biomarker in cardiac diseases. Curr Top Med Chem. 2013;13(2):82\u201394.","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"4609_CR23","doi-asserted-by":"publisher","first-page":"101067","DOI":"10.1016\/j.cpcardiol.2021.101067","volume":"48","author":"LC Duque-Ossa","year":"2023","unstructured":"Duque-Ossa LC, Garc\u00eda-Ferrera B, Reyes-Retana JA. Troponin I as a biomarker for early detection of acute myocardial infarction. Curr Probl Cardiol. 2023;48(5):101067.","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"4609_CR24","first-page":"261","volume":"20","author":"Y Peng","year":"2020","unstructured":"Peng Y, Wei H. Role of Recombinant human brain natriuretic peptide combined with sodium Nitroprusside in improving quality of life and cardiac function in patients with acute heart failure. Experimental Therapeutic Med. 2020;20(1):261\u20138.","journal-title":"Experimental Therapeutic Med"},{"issue":"4","key":"4609_CR25","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/ehf2.13987","volume":"9","author":"JC Luo","year":"2022","unstructured":"Luo JC, Zhang YJ, Huang DL, Wang H, Luo MH, Hou JY, Hao GW, Su Y, Tu GW, Luo Z. Recombinant human brain natriuretic peptide ameliorates venous return function in congestive heart failure. ESC Heart Fail. 2022;9(4):2635\u201344.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"4609_CR26","first-page":"422","volume":"62","author":"M Ye","year":"2023","unstructured":"Ye M, Wang X, Sun Y, Huang J, Zeng YJ, Gao H. [Clinical observation of Qiliqiangxin capsule combined with Recombinant human brain natriuretic peptide in patients with acute heart failure]. Zhonghua Nei Ke Za Zhi. 2023;62(4):422\u20136.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"16","key":"4609_CR27","doi-asserted-by":"publisher","first-page":"e25621","DOI":"10.1097\/MD.0000000000025621","volume":"100","author":"Z Pang","year":"2021","unstructured":"Pang Z, Pan C, Yao Z, Ren Y, Tian L, Cui J, Liu X, Zhang L, Chen Y. A study of the sequential treatment of acute heart failure with Sacubitril\/valsartan by Recombinant human brain natriuretic peptide: A randomized controlled trial. Medicine. 2021;100(16):e25621.","journal-title":"Medicine"},{"issue":"2","key":"4609_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1536\/ihj.21-170","volume":"63","author":"W Xu","year":"2022","unstructured":"Xu W, Wang W, Xiao Q, Wang Y, Zhu B, Wang P. Effect of Recombinant human brain natriuretic peptide on acute carbon monoxide poisoning complicated with heart failure with reduced ejection fraction. Int Heart J. 2022;63(2):312\u20138.","journal-title":"Int Heart J"},{"issue":"3","key":"4609_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, Anker SD, Atherton J, B\u00f6hm M, Butler J, et al. Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure: endorsed by the Canadian heart failure society, heart failure association of India, cardiac society of Australia and new Zealand, and Chinese heart failure association. Eur J Heart Fail. 2021;23(3):352\u201380.","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"4609_CR30","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/heartjnl-2021-319605","volume":"108","author":"AB Gevaert","year":"2022","unstructured":"Gevaert AB, Kataria R, Zannad F, Sauer AJ, Damman K, Sharma K, Shah SJ, Van Spall HGC. Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management. Heart. 2022;108(17):1342\u201350.","journal-title":"Heart"},{"key":"4609_CR31","doi-asserted-by":"publisher","first-page":"108185","DOI":"10.1016\/j.pharmthera.2022.108185","volume":"238","author":"H Tsutsui","year":"2022","unstructured":"Tsutsui H. Recent advances in the Pharmacological therapy of chronic heart failure: evidence and guidelines. Pharmacol Ther. 2022;238:108185.","journal-title":"Pharmacol Ther"},{"issue":"22","key":"4609_CR32","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.jacc.2023.03.426","volume":"81","author":"M Pagnesi","year":"2023","unstructured":"Pagnesi M, Metra M, Cohen-Solal A, Edwards C, Adamo M, Tomasoni D, Lam CSP, Chioncel O, Diaz R, Filippatos G, et al. Uptitrating treatment after heart failure hospitalization across the spectrum of left ventricular ejection fraction. J Am Coll Cardiol. 2023;81(22):2131\u201344.","journal-title":"J Am Coll Cardiol"},{"key":"4609_CR33","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2147\/DDDT.S295214","volume":"15","author":"N Conti","year":"2021","unstructured":"Conti N, Gatti M, Raschi E, Diemberger I, Potena L. Evidence and current use of Levosimendan in the treatment of heart failure: filling the gap. Drug Des Devel Ther. 2021;15:3391\u2013409.","journal-title":"Drug Des Devel Ther"},{"key":"4609_CR34","doi-asserted-by":"publisher","first-page":"108172","DOI":"10.1016\/j.pharmthera.2022.108172","volume":"237","author":"MJ Chapman","year":"2022","unstructured":"Chapman MJ, Zamorano JL, Parhofer KG. Reducing residual cardiovascular risk in Europe: therapeutic implications of European medicines agency approval of icosapent Ethyl\/eicosapentaenoic acid. Pharmacol Ther. 2022;237:108172.","journal-title":"Pharmacol Ther"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04609-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T02:42:18Z","timestamp":1742006538000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04609-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4609"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04609-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the Ethics Committee of Aerospace Center Hospital in accordance with regulatory and ethical guidelines and performed in accordance with the ethical standards set forth in the Declaration of Helsinki. Written informed consent was obtained from all participants prior to conducting the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}